Financial News

Medifocus Inc (TSV: MFS )

0.0100 CAD UNCHANGED

Last Price Updated: 10:34 AM EDT, Sep 4, 2020 Add to My Watchlist

Price and Volume

Volume	0
Open	0.0100
Bid (Size)	0.0050 (13,510)
Ask (Size)	0.0100 (3,990)
Prev. Close	0.0100
Today's Range	0.0100 - 0.0100
52wk Range	0.0050 - 0.0150
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Medifocus, Inc. Announces Increase in Revenue and Positive Cash Flow from Operation in Fiscal Year Ended March 31, 2019 and Global Market Expansion with Prolieve(R) Procedures Performed in Singapore

August 29, 2019

Medifocus, Inc. Announces Global Market Expansion with Prolieve® Performed and Reimbursed by Insurance Carriers in Hong Kong

January 03, 2019

Medifocus, Inc. (OTCQB: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign...

Performance

YTD	N/A	N/A
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	N/A	N/A
1 Year	+100.00%	+100.00%

More News

Medifocus, Inc. Announces Recent Publication Highlighting Its Focal Therapy for Prostate and Breast Cancer Treatment Initiatives

December 27, 2018

Uptick Newswire’s Stock Day Podcast Hosts Medifocus, Inc.’s CEO to Discuss Their Minimally Invasive Breakthrough Treatments for Prostate and Breast Cancers

December 10, 2018

First Water Announces Managed FP&A Solutions (MFS) for Small and MidSize Businesses to Accelerate Finance Capabilities

May 21, 2019

Medifocus, Inc. Announces FDA PMA Supplement Approval for New Labeling Based on Successful Completion of FDA Post Approval Study (PAS) for the Prolieve® Thermodilatation™ Device

December 03, 2018

Medifocus, Inc. Submits For New Patent Titled “Thermodilatation and Thermocompression to Facilitate Targeted Cluster Tissue Ablation and Immune Response”

November 29, 2018

Medifocus, Inc. Announces 26% Increase in Revenue in Recent Quarter and Positive Cash Flow from Operation for the Six Months Ended Sept 30, 2018

November 27, 2018

Medifocus Inc.’s General Manager and Medical Director Discuss Their Breakthrough Products with Uptick Newswire’s Stock Day Podcast

October 31, 2018

Medifocus, Inc. Announces Successful Completion of FDA Post Approval Study (PAS) for the Prolieve (R) Thermodilatation(TM) System

June 05, 2018

Medifocus, Inc. Expands Its Reach into the Israeli Market with Amos Gazit Ltd. for Its Prolieve(R) Thermodilatation for BPH Therapy and Announces Significant Debt Conversion into Shares

January 09, 2018

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Medifocus Inc (TSV: MFS )

Price and Volume

Top News

Performance

More News

Popular Pages